Home
HelpTest ID ALPGP Alport Syndrome Gene Panel, Varies
Ordering Guidance
Customization of this panel and single gene analysis for any gene present on this panel are available. For more information see CGPH / Custom Gene Panel, Hereditary, Next-Generation Sequencing, Varies.
Targeted testing for familial variants (also called site-specific or known mutations testing) is available for the genes on this panel. See FMTT / Familial Variant, Targeted Testing, Varies. To obtain more information about this testing option, call 800-533-1710.
Shipping Instructions
Specimen preferred to arrive within 96 hours of collection.
Specimen Required
Patient Preparation: A previous bone marrow transplant from an allogenic donor will interfere with testing. Call 800-533-1710 for instructions for testing patients who have received a bone marrow transplant.
Container/Tube:
Preferred: Lavender top (EDTA) or yellow top (ACD)
Acceptable: Any anticoagulant
Specimen Volume: 3 mL
Collection Instructions:
1. Invert several times to mix blood.
2. Send whole blood specimen in original tube. Do not aliquot.
Specimen Stability Information: Ambient (preferred)/Refrigerated
Forms
1. New York Clients-Informed consent is required. Document on the request form or electronic order that a copy is on file. The following documents are available:
-Informed Consent for Genetic Testing (T576)
-Informed Consent for Genetic Testing-Spanish (T826)
2. Hereditary Renal Genetic Testing Patient Information (T918)
3. If not ordering electronically, complete, print, and send a Renal Diagnostics Test Request (T830) with the specimen.
Useful For
Providing a genetic evaluation for patients with a personal or family history suggestive of Alport syndrome
Establishing a diagnosis of Alport syndrome
Genetics Test Information
This test utilizes next generation sequencing to detect single nucleotide, deletion-insertion, and copy number variants in four genes associated with Alport syndrome: COL4A3, COL4A4, COL4A5, and COL4A6. See Targeted Genes and Methodology Details for Alport Syndrome Gene Panel and Method Description for additional details.
Identification of a disease-causing variant may assist with diagnosis, prognosis, clinical management, familial screening, and genetic counseling for Alport syndrome.
Special Instructions
Method Name
Sequence Capture Next-Generation Sequencing (NGS)/Sanger Sequencing
Reporting Name
Alport Syndrome Gene PanelSpecimen Type
VariesSpecimen Minimum Volume
1 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Varies | Varies | ||
Reference Values
An interpretive report will be provided.
Day(s) Performed
Varies
Report Available
28 to 42 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
81407
81408 x 2
81479 (if appropriate for government payers)
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| ALPGP | Alport Syndrome Gene Panel | 51966-0 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 618045 | Test Description | 62364-5 |
| 618046 | Specimen | 31208-2 |
| 618047 | Source | 31208-2 |
| 618048 | Result Summary | 50397-9 |
| 618049 | Result | 82939-0 |
| 618050 | Interpretation | 69047-9 |
| 618051 | Additional Results | 82939-0 |
| 618052 | Resources | 99622-3 |
| 618053 | Additional Information | 48767-8 |
| 618054 | Method | 85069-3 |
| 618055 | Genes Analyzed | 48018-6 |
| 618056 | Disclaimer | 62364-5 |
| 618057 | Released By | 18771-6 |